Nucleos(t)ide analogue(s)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Nucleos(t)ide analogue(s), covering 2025-07-17 to 2025-07-17. Get the full timeline:
Most recent: Clinical Trial Update: HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients [Phase 1]